Non trovato

Matze

@spatzis

1Mes·

Let's see what happens...

06.12

Formycon

Acquistato x58,82 a 51,00 €

3.000,00 €

8 Commenti

Lukas1000@Lukas1000

1Mes

What will

•

ThemenmitKopf@topicswithhead

1Mes

Good buy

•

Matze@spatzis

1Mes

@topicswithhead Why do you think that? Kind regards

••

ThemenmitKopf@topicswithhead

1Mes

@dividend_dynamo_824 you don't know yourself why you are in or how. Interesting sector in which you are also marketing with an interesting concept. Biosimmilar is simply a highly lucrative area if you do it right

••

Matze@spatzis

1Mes

@topicswithhead 😀 I already know why I'm in. I was just interested in your opinion ;)

••

ThemenmitKopf@topicswithhead

1Mes

@dividend_dynamo_824 is just very lucrative and in principle much simpler than the other concepts, which is why you hopefully also get better and safer margins. But there are also other interesting providers, such as Sandoz. Why did you go in?

••

Matze@spatzis

1Mes

@topicswithhead An important approval for a biosimilar candidate is expected in mid-January. So it could continue to go up. Besides, you already said that the sector is simply very interesting 👍🏼

••

Matze@spatzis

3Settimana

Will be something

••